Bioorganic & Medicinal Chemistry Letters
Synthesis of apoptotic chalcone analogues in HepG2 human
hepatocellular carcinoma cells
Cheon-Soo Park a,y, Yongchel Ahn b,y, Dahae Lee c, Sung Won Moon d,e, Ki Hyun Kim f, Noriko Yamabe c,
Gwi Seo Hwang c, Hyuk Jai Jang a, Heesu Lee g, Ki Sung Kang c, , Jae Wook Lee e,h,
⇑
⇑
a Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung 210-711, Republic of Korea
b Department of Hematology and Oncology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung 210-711, Republic of Korea
c College of Korean Medicine, Gachon University, Seongnam 461-701, Republic of Korea
d Department of Chemistry, Gangneung Wonju National University, Gangneung 210-340, Republic of Korea
e Natural Product Research Center, Korea Institute of Science and Technology, Gangneung 210-340, Republic of Korea
f Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
g Department of Oral Anatomy, College of Dentistry, Gangneung Wonju National University, 201-340, Republic of Korea
h Department of Biological Chemistry, University of Science and Technology (UST), Daejeon 305-333, Republic of Korea
a r t i c l e i n f o
a b s t r a c t
Article history:
Eight chalcone analogues were prepared and evaluated for their cytotoxic effects in human hepatoma
HepG2 cells. Compound 5 had a potent cytotoxic effect. The percentage of apoptotic cells was signifi-
cantly higher in compound 5-treated cells than in control cells. Exposure to compound 5 for 24 h induced
cleavage of caspase-8 and -3, and poly (ADP-ribose) polymerase (PARP). Our findings suggest that com-
pound 5 is the active chalcone analogue that contributes to cell death in HepG2 cells via the extrinsic
apoptotic pathway.
Received 1 October 2015
Revised 28 October 2015
Accepted 30 October 2015
Available online 31 October 2015
Keywords:
Chalcone
Anticancer
HepG2
Ó 2015 Elsevier Ltd. All rights reserved.
Apoptosis
Hepatocellular carcinoma (HCC) is a highly lethal tumor that
commonly occurs in patients with chronic liver disease and cirrho-
sis.1 HCC has a poor prognosis due to its high recurrence rate and
resistance to chemotherapy.2 To date, liver transplantation is the
best form of treatment because it removes the tumor as well as
damaged hepatic tissues that may provoke chronic liver disorders.1
Several experimental and clinical investigations have occurred,
with the goal of preventing recurrence and secondary tumors
and improve the clinical outcome of HCC patients.3
Chalcone is an aromatic ketone or enone structure that forms
the central core and exhibits a wide range of biological activities,
including anticancer effects.4 Isoliquiritigenin is a natural pigment
with the simple chalcone structure 4,20,40-trihydroxychalcone.
Isoliquiritigenin inhibits the proliferation of human hepatoma cells
(HepG2) by G2/M phase arrest and programmed cell death.5
Xanthohumol, the major prenylated chalcone found in hops,
induces apoptosis in two HCC cell lines (HepG2 and Huh7).6 In
addition, chalcone derivatives from the fern Cyclosorus parasiticus
exhibit potent cytotoxicity against six cancer cell lines (e.g., lung
cancer A549, HepG2, breast cancer MCF-7 and MDA-MB-231,
leukemia ALL-SIL, and pancreatic cancer SW1990).7 Based on these
findings, in this study we synthesized eight chalcone analogues
and evaluated their cytotoxic effects on human hepatoma HepG2
cells (see Fig. 1).
We synthesized chalcone analogues (1–8) with methoxy or
halogenated groups that have electron-donating or electron-
accepting properties. For synthesis, we used Claisen–Schmidt
condensation between substituted acetophenone and benzalde-
hyde in the presence of aqueous NaOH solution.8 A reaction
mixture of benzaldehyde and acetophenone in EtOH treated with
NaOH solution was refluxed overnight. The synthesized chalcone
derivatives were purified by either silica gel column chromatogra-
phy or recrystallization with EtOH. All products were characterized
using 1H nuclear magnetic resonance (NMR), 13C NMR, and liquid
chromatography–mass spectrometry (LC–MS).
Cytotoxic effects of the chalcone analogues were assessed in
HepG2 cells using a MTT assay.9 As shown in Figure 2, two
compounds (3 and 5), each possessing a 3,5-dimethoxy-4-bromo
phenyl group, inhibited HepG2 cell growth by more than 50%. Of
⇑
Corresponding authors. Tel.: +82 33 750 5402; fax: +82 33 750 5416 (K.K.S.);
tel./fax: +82 33 650 3502 (L.J.W.).
These authors contributed equally to this work.
y
0960-894X/Ó 2015 Elsevier Ltd. All rights reserved.